Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209,162 | $357,594 | $252,952 | $252,952 |
| - Cash | $35,014 | $121,466 | $77,335 | $135,860 |
| + Debt | $9,924 | $11,638 | $13,482 | $0 |
| Enterprise Value | $184,072 | $247,766 | $189,099 | $117,092 |
| Revenue | $0 | $0 | $654 | $1,657 |
| % Growth | – | -100% | -60.5% | – |
| Gross Profit | $0 | $0 | $654 | $1,657 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$96,194 | -$64,346 | -$58,041 | -$50,609 |
| % Margin | – | – | -8,874.8% | -3,054.3% |
| Net Income | -$98,333 | -$66,394 | -$59,277 | -$50,622 |
| % Margin | – | – | -9,063.8% | -3,055% |
| EPS Diluted | -3.09 | -2.49 | -2.4 | -2.01 |
| % Growth | -24.1% | -3.8% | -19.4% | – |
| Operating Cash Flow | -$81,151 | -$59,496 | -$54,560 | -$44,182 |
| Capital Expenditures | -$481 | -$165 | -$901 | -$188 |
| Free Cash Flow | -$81,632 | -$59,661 | -$55,461 | -$44,370 |